Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based coronavirus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results